The Board denied a rating in excess of 30 percent for endometriosis and from December 1, 2018, for the hysterectomy associated with endometriosis.

The deciding factor: The evidence did not support a higher rating as it was persuasively against finding lesions involving bowel or bladder confirmed by laparoscopy, pelvic pain or heavy or irregular bleeding not controlled by treatment, and bowel or bladder symptoms.

Claimed conditions

endometriosis, hysterectomy associated with endometriosis

How they argued it

Direct service connection

Exposure basis

None

Rating assigned

None in this decision

Decision date

March 14, 2025

Citation

25003563

Want to see how appeals like this one tend to go? Appeals like mine